UpFront
-
WhatsApp sues India's government to stop new Internet rules
Suing India's government is a highly unusual step by WhatsApp, which has rarely engaged with national governments in court
-
IDBI Bank: Time to revisit its vision
IDBI Bank has exited the PCA framework with its brand value intact. But it needs to restart its growth engine to succeed as a turnaround bank, and make money for primary investor LIC
-
Apple's 'Fortnite' trial ends with pointed questions and a toast to Popeyes
For the past three weeks, Apple has defended itself in a federal courtroom in Oakland, California, against claims that it abused its power over the iPhone App Store, in one of the biggest antitrust trials in Silicon Valley's history
-
After pursuing terrorists, Delhi Police Special Cell investigates Twitter's 'manipulated media' policy
In the middle of a lockdown, Delhi Police's Special Cell turns up at the offices of social media platform Twitter in Delhi NCR to get "satisfactory" answers on its tweet labelling policy
-
Delhi considers lifting Covid-19 limits, despite vaccine shortage
India does not have the vaccine manufacturing capacity to inoculate a big portion of its population anytime soon, while the prospect of importing new supplies from abroad has bogged down amid squabbling between the central and local governments
-
Can wildfires be prevented in a world dealing with climate change?
India recorded 82,170 forest fire alerts from April 1 to 14, nearly doubling from 43,031 in the same period in 2020. Forest fires, wildfires and their alerts in the country have gone up sharply in recent times, posing a serious threat to our environment, wildlife and biodiversity
-
Pakistan's private vaccine sales highlight the rich-poor divide
Critics say the decision will deepen the divisions within the country, where a large section of the society lives under the poverty line
-
As India stumbles, one state charts its own Covid-19 course
Though supplies have tightened, Kerala's hospitals enjoy access to oxygen, with officials having expanded production months ago while coordination centres, called war rooms, direct patients and resources
-
Will made-in-India Sputnik V be the country's salvation?
As India struggles with vaccine shortages and a laggard inoculation programme, a clutch of local manufacturers, including Hetero Group of Companies, Gland Pharma and Stelis Biopharma has set out to produce the contentious Sputnik V vaccine in a bid to alleviate supply constraints. Subscribe to Forbes India for early access
-
Immunising India: Can Sputnik V save the country?
At least six Indian pharma companies, including Hetero Group, are on track to make some 900 million doses of the Russian vaccine. As India gears up to manufacture the Sputnik there are questions galore
